SCHEMBL7552152

SCHEMBL7552152

N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1C(F)(F)F

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 15/20 0.71
CXCR1 P25024 11/20 0.71
ADRB3 P13945 1/20 0.56
TSPO P30536 1/20 0.56
SLC6A3 Q01959 1/20 0.56
HTT P42858 3/20 0.48
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46
GAA P10253 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
MAPT P10636 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6550053 0.83 CXCR2 (1.00) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL13951815 0.81 CXCR2 (0.76) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL7553831 0.81 CXCR2 (1.00) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL7550202 0.81 CXCR2 (0.53) CXCR2CXCR1MEN1KMT2ALMNA
SCHEMBL6823256 0.80 CXCR2 (0.75) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL3710377 0.80 CXCR2 (0.75) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL7553940 0.80 CXCR2 (0.74) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL6550799 0.79 CXCR2 (0.68) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL6548955 0.77 CXCR2 (0.70) CXCR2CXCR1ADRB3TSPOSLC6A3
SCHEMBL27608153 0.76 CXCR2 (0.68) CXCR2CXCR1ADRB3TSPOSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128321-A1 IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2002-09-12 US disclosed
US-6262113-B1 HYDROXY- OR MERCAPTO-PHENYLUREAS SMITHKLINE BEECHAM CORPORATION 2001-07-17 US disclosed
US-6211373-B1 Phenyl urea antagonists of the IL-8 receptor SMITHKLINE BEECHAM CORPORATION 2001-04-03 US disclosed
US-5780483-A IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION (US) 1998-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128321-A1 IL-8 receptor antagonists CXCL8, CCR8, IL1RN CXCR2 15/4885CXCR1 21/4885ADRB3 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.